Scoping Review of Economic Analyses of Rare Kidney Diseases

Introduction: Rare kidney diseases (RKDs) place a substantial economic burden on patients and health systems, the extent of which is unknown and may be systematically underestimated by health economic techniques. We aimed to investigate the economic burden and cost-effectiveness evidence base for RK...

Full description

Bibliographic Details
Published in:Kidney International Reports
Main Authors: Blake Angell, Siyuan Wang, Thomas Gadsden, Monica Moorthy, Charu Malik, Jonathan Barratt, Olivier Devuyst, Ifeoma I. Ulasi, Daniel P. Gale, Agnivo Sengupta, Anna Palagyi, Vivekanand Jha, Stephen Jan
Format: Article
Language:English
Published: Elsevier 2024-12-01
Subjects:
cost-effectiveness
economic burden
rare kidney disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924019223

Internet

http://www.sciencedirect.com/science/article/pii/S2468024924019223

Similar Items